+48.7%
CVS vs CCL
-40.8%
+89.5%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | CCL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.0% | -3.6% | +4.6% | +1.4% |
| 7D | -9.5% | -9.0% | -0.5% | -8.6% |
| 30D | -12.9% | -2.1% | -10.8% | -13.0% |
| 3M | -13.1% | +5.3% | -18.4% | -14.1% |
| 6M | -12.2% | +3.2% | -15.4% | -13.2% |
| YTD | +5.0% | -11.1% | +16.1% | +4.8% |
| 1Y | +9.6% | +7.2% | +2.3% | +6.7% |
| 3Y | +32.6% | +86.4% | -53.8% | +17.8% |
| 5Y | +2.6% | +32.5% | -30.0% | -9.4% |
| All | +48.7% | -40.8% | +89.5% | +56.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CCL.
Daily Out/Under-Performance
Portfolio return minus CCL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CCL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded CCL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling